Cresco Labs Inc. (CRLBF)
Cresco Labs Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Chicago, IL, US. The stock last traded at $0.76, down 1.97% on the session, giving a market capitalisation of $270.8M. On trailing twelve-month figures it carries a trailing P/E of -2.52, a net margin of -15.9%. Its beta of 1.72 implies it has historically moved more than the broad market.
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
Cresco Labs Inc. is most often compared with the following Healthcare names: